AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Cardio Diagnostics Holdings, Inc.
Video analysis: CDIO
All videosNo video analysis for this stock yet. Request one from our team.
News: CDIO
Cardio Diagnostics (NASDAQ:CDIO) & Sutro Biopharma (NASDAQ:STRO) Head-To-Head Analysis
Sutro Biopharma (NASDAQ: STRO - Get Free Report) and Cardio Diagnostics (NASDAQ: CDIO - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability. Profitability This table compares Sutro Biopharma and
Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges
[url="]Cardio Diagnostics Holdings, Inc.[/url] (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the release of a new edit
Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has released a new edition of the company's rural health report: The State of Rural Hospitals and Cardiovascular Care.
Cardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives Prepared Remarks Transcript
Cardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives Prepared Remarks Transcript
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics launched its in-house, high-complexity CLIA-certified laboratory in Iowa City, Iowa.
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. will host an investor conference call on Thursday, August 20, 2026, at 3 p.m. Central Time.
Atlas Healthcare Physicians to Cover Cardio Diagnostics' Precision Cardiovascular Medicine Tests Across Its Network
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced that Atlas Healthcare Physicians (AHP) will cover Cardio Diagnostics' tests, Epi+Gen CHD™ and PrecisionCHD™.
Similar companies
-
Addex Therapeutics Ltd
ADXN
·
NASDAQ
Compare
-
Brainstorm Cell Therapeutics Inc.
BCLI
·
Other OTC
Compare
-
NeuroSense Therapeutics Ltd.
NRSN
·
NASDAQ
Compare
-
Matinas BioPharma Holdings, Inc.
MTNB
·
New York Stock Exchange Arca
Compare
-
Creative Medical Technology Holdings, Inc.
CELZ
·
NASDAQ
Compare
-
Adial Pharmaceuticals, Inc.
ADIL
·
NASDAQ
Compare